Methyl 4,6,7,8,9,10-hexahydro-2-hydroxy-4-oxopyrido[1,2-a]azepine-1-carboxylate, 95+%, 100mg

1-Methoxy-2-vinylbenzene, 97%, 100g

2-(Morpholin-2-yl)ethan-1-ol hydrochloride, 98%, 500mg

3,5-Dimethylisoxazol-4-ol, 95.0%, 100mg

2-Hydroxy-4-methyl-5-nitropyridine, 98.0%, 10g

Ethyl 4-ethylpiperidine-4-carboxylate hydrochloride, 95.0%, 250mg

Volumetric flasks class A Brown glass, 100 ml, 12/21, 2 Piece(s)

Trans-2-(methoxycarbonyl)cyclobutanecarboxylic acid, 95.0%, 5g

N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)thiomorpholine-4-carboxamide, 98%, 250mg

3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-2,6-DICARBOXYLIC ACID 2-TERT-BUTYL ESTER 6-METHYL ESTER, 95.0%, 500mg

4,6-Dichloro-2-fluoropyrimidine, 95.0%, 1g

7-hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde, 98%, 50mg

Silica, for chromatography, 250 g, plastic packaging.